Hypotheses for mechanisms linking shiftwork and cancer
Introduction
The International Agency for Research on Cancer (IARC) has categorized “shift-work that involves circadian disruption” as “probably carcinogenic to humans (Group 2A)” [1]. The IARC Working Group concluded that the experimental and mechanistic evidence, including results from different rodent models, was sufficient to conclude that there was a causal association. However, since the epidemiological evidence was considered to be limited, the conclusion of the IARC expert group was that shiftwork was “probably carcinogenic.” In terms of the epidemiologic evidence, a meta-analysis of 30 epidemiological studies in female and male flight- and shift-personnel found that relative risks for two of the most common types of cancers (breast and prostate) may be increased by some 40–70% [2]. However, while it is possible that some cancers are causally associated with shiftwork, there remain a number of problems with the existing epidemiological data. The IARC Working Group identified these as:
- •
Most studies have been based on just a single profession.
- •
Many had limited ability to adjust for confounders.
- •
There was little ability to adjust for detection bias.
- •
Definitions of shiftwork have been inconsistent and broad.
In developed countries, approximately 20% of the population undertake shiftwork [1], and we are unlikely to be able to eliminate shiftwork from current work practices. However, there are aspects of shiftwork that we can change and there may be facets of individual susceptibility that we can identify and target for prevention. Central to the development of preventive approaches is to establish which aspects of shiftwork contribute to any increased risk of cancer. As a first step, we need to clearly define the possible mechanisms by which shiftwork could have an effect. Only then are we able to design studies that can specifically discriminate between these mechanisms and allow us to identify which mechanism is responsible for any effect. Evidence-based interventions can then be designed to minimise such effects.
Section snippets
Hypotheses for mechanisms linking shiftwork and cancer
There are several candidate mechanisms identified so far from animal and in vitro experiments, and from epidemiological studies, that could provide a biological rationale for the associations between shiftwork and cancer. If these are further substantiated in well-designed epidemiological studies, they could be interpreted as reflecting a cause and effect phenomenon [3].
We have defined five possible mechanisms by which the proposed link between shiftwork and cancer might act [4]. We also need
Discussion
We have presented five possible mechanisms for how shiftwork may be related to cancer. The evidence for each of these mechanisms can be summarized as below:
- •
Phase shift – animal experiments have reported links between clock gene function and tumor cell induction and growth, and epidemiological studies have shown association between clock gene polymorphisms and some cancers, however, no studies have shown that shift workers have clock gene polymorphism or gene expression linked to cancer.
- •
Conclusions
Given the complex set of possible mechanisms and contributing factors, many of which have only gained wider attention recently, it is no surprise that the initial epidemiological studies were unable to provide strong evidence of an association between shiftwork and increased risk of cancer. Since the mechanism by which shiftwork might have its effect is not known, the best metrics for measuring “exposure dose” are difficult to quantify. Indeed the definition of shiftwork is uncertain and hence
Conflict of interest statement
None to declare.
Acknowledgements
Lin Fritschi is supported by a National Health and Medical Research Council Fellowship. Thomas C. Erren is currently appointed as visiting scholar at the University of California, Berkeley. No grants were received for this work.
References (85)
- et al.
The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells
Mol Cell
(2006) Circadian tempo: a paradigm for genome stability?
Med Hypotheses
(2007)- et al.
Cancer-related transcriptional targets of the circadian gene NPAS2 identified by genome-wide ChIP-on-chip analysis
Cancer Lett
(2009) - et al.
Melatonin’s growth-inhibitory effect on hepatoma AH 130 in the rat
Cancer Lett
(1998) - et al.
Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions
Cancer Detect Prev.
(2006) - et al.
Effect of melatonin on mitotic and proliferation indices, and sister chromatid exchange in human blood lymphocytes
Mutat Res Fundam Mol Mech Mutag
(1996) - et al.
The hallmarks of cancer
Cell
(2000) - et al.
Non-rod, non-cone photoreception in the vertebrates
Prog Retin Eye Res
(2002) - et al.
The chronosense–what light tells man about biological time
Med Hypotheses
(2004) - et al.
Preventing cancers caused by chronodisruption: blocking blue light alone is unlikely to do the trick
Med Hypotheses
(2009)
Melatonin, sleep disturbance and cancer risk
Sleep Med Rev
The metabolic consequences of sleep deprivation
Sleep Med Rev
Is sleep duration related to obesity? A critical review of the epidemiological evidence
Sleep Med Rev
Prevalence of main cancer lifestyle risk factors in Europe in 2000
Eur J Cancer
Relationships between sleep, physical activity and human health
Physiol Behav
Chronodisruption and cancer
Naturwissenschaften
Shift work, chronodisruption and cancer?–The IARC 2007 challenge for research and prevention and 10 theses from the Cologne Colloquium 2008
Scand J Work Environ Health
Shift work and cancer
Br Med J
Biological clocks and shift work: circadian dysregulation and potential long-term effects
Cancer Causes Control
Mammalian circadian biology: elucidating genome-wide levels of temporal organization
Annu Rev Genomics Hum Genet
The circadian clock: pacemaker and tumour suppressor
Nat Rev Cancer
Tumor suppression and circadian function
J Biol Rhythms
The clock gene Per2 links the circadian system to the estrogen receptor
Oncogene
The circadian gene NPAS2, a putative tumor suppressor, is involved in DNA damage response
Mol Cancer Res
Tumor suppression by the mammalian Period genes
Cancer Causes Control
Circadian clock and breast cancer: a molecular link
Cell Cycle
Period 2 mutation accelerates ApcMin/+ tumorigenesis
Mol Cancer Res
Period-2: a tumor suppressor gene in breast cancer
J Circadian Rhythms
Down regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm
Breast Cancer Res Treat
Circadian gene mPer2 overexpression induces cancer cell apoptosis
Cancer Sci
Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers
Carcinogenesis
CLOCK in breast tumorigenesis: genetic, epigenetic, and transcriptional profiling analyses
Cancer Res
Disturbance of circadian gene expression in breast cancer
Virchows Arch
Disturbance of circadian gene expression in hepatocellular carcinoma
Mol Carcinog
Downregulation of circadian clock genes in chronic myeloid leukemia: alternative methylation pattern of hPER3
Cancer Sci
Period3 structural variation: a circadian biomarker associated with breast cancer in young women
Cancer Epidemiol Biomarkers Prev
Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk
Breast Cancer Res Treat
Variants in circadian genes and prostate cancer risk: a population-based study in China
Prostate Cancer Prostatic Dis
Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study
Cancer Res
Clock-cancer connection in non-Hodgkin’s lymphoma: a genetic association study and pathway analysis of the circadian gene cryptochrome 2
Cancer Res
Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin’s lymphoma
Int J Cancer
Cited by (163)
Circadian rhythms, gut microbiota, and diet: Possible implications for health
2023, Nutrition, Metabolism and Cardiovascular DiseasesCircadian effects on UV-induced damage and mutations
2022, Mutation Research - Reviews in Mutation Research